Lipid-lowering drugs Cetilistat CAS No:282526-98-1

Lipid-lowering drugs Cetilistat CAS No:282526-98-1

Min.Order / FOB Price:Get Latest Price

25 Kilogram	FOB Price: USD 1000.0000

25 Kilogram

FOB Price: USD 1000.0000

Min.Order :25 Kilogram
Purity: 99%
Payment Terms : T/T

Keywords

Lipid-lowering drugs Cetilistat Cetilistat Cetilistat CAS No:282526-98-1

Quick Details

Appearance:A WHITE CRYSTALLINE POWDER
Application:Lipid-lowering drugs
PackAge:25kg/drum
ProductionCapacity:100|Kiloliter|Day
Storage:Normal
Transportation:by air

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Why choose us

1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin

Details:

Product Information

Product Name	Cetilistat
CAS Number	282526-98-1
Molecular Formula	C25H39NO3
Molecular Weight	560.01401.58
Purity	99%
Appearance	White Powder
Melting Point	72.0 to 76.0 °C
Boiling Point	509.7±43.0 °C(Predicted)
EINECS Number	1308068-626-2
MOQ	1 kg

Cetilistat is a lipase inhibitor discovered by UK-based Alizyme Therapeutics Limited. Norgine acquired all rights to the product from Alizyme in October 2009. In 2003 Takeda acquired the rights for development and commercialisation for Japan. On September 20, 2013, the Japanese Ministry of Health, Labour and Welfare has approved the New Drug Application (NDA) of Cetilistat (OBLEAN® Tablets 120mg) for the treatment of obesity with complications, which is the first therapy that controls lipid absorption approved in Japan for the treatment of obesity with complications.

View All

Visit Store

Lipid-lowering drug...